{
    "N/R/U": null,
    "Applicant": "GC Biopharma Corp. ",
    "BLA Number": "125743",
    "Proprietary Name": "Alyglo",
    "Proper Name": "immune globulin intravenous, human-stwk",
    "BLA Type": "351(a)",
    "Strength": "10% 100MG/ML",
    "Dosage Form": "Injection ",
    "Route of Administration": "Intravenous",
    "Product Presentation": "Single-Dose Vial",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "15-Dec-23",
    "Ref. Product Proper Name": null,
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "0",
    "Submission Type": "Original",
    "License Number": "2033",
    "Product Number": "1",
    "Center": "CBER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null,
    "drug": [
        {
            "name": "immune globulin intravenous, human-stwk"
        }
    ]
}